Skip to main content
logo
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.34
+0.35 (3.18%)
Mar 25, 2026, 4:00 PM EDT - Market closed

Keros Therapeutics Revenue

In the year 2025, Keros Therapeutics had annual revenue of $244.06M with 6,774.96% growth. Keros Therapeutics had revenue of $385.00K in the quarter ending December 31, 2025, a decrease of -87.34%.

Revenue (ttm)
$244.06M
Revenue Growth
+6,774.96%
P/S Ratio
0.92
Revenue / Employee
$3,128,987
Employees
78
Market Cap
223.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025244.06M240.51M6,774.96%
Dec 31, 20243.55M3.40M2,250.99%
Dec 31, 2023151.00K--
Dec 31, 2022---
Dec 31, 202120.10M--
Dec 31, 2020---
Dec 31, 201910.00M--
Dec 31, 201810.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Editas Medicine40.52M
Voyager Therapeutics40.37M
Alector21.05M
Sol-Gel Technologies19.39M
MediWound16.96M
Tonix Pharmaceuticals Holding13.11M
Camp4 Therapeutics3.50M
Revenue Rankings

KROS News

More News